Mithra Pharmaceuticals S.A.
Mithra Pharmaceuticals S.A. (MITPF) Revenue
Annual & quarterly revenue history · segment & region breakdown
MITPF · revenue · updated Jun 8, 2026
Core revenue metrics
Trailing 12 monthsMithra Pharmaceuticals S.A. trailing twelve-month (TTM) revenue is $0.11B, a decrease of 40.06% year-over-year from $0.04B in FY2023.
Revenue trend
2023 – 2012 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2023-12-31 | $0.04B | -$0.03B | -40.06% |
| 2022-12-31 | $0.07B | +$0.04B | +195.56% |
| 2021-12-31 | $0.02B | +$0.01B | +151.03% |
| 2020-12-31 | $0.01B | -$0.09B | -90.64% |
| 2019-12-31 | $0.10B | +$0.04B | +66.77% |
| 2018-12-31 | $0.06B | +$0.03B | +80.63% |
| 2017-12-31 | $0.03B | +$0.01B | +42.61% |
| 2016-12-31 | $0.02B | +$0.00B | +9.95% |
| 2015-12-31 | $0.02B | +$0.00B | +7.34% |
| 2014-12-31 | $0.02B | +$0.00B | +7.70% |
Compare revenue vs peers
Drug Manufacturers - Specialty & GenericCompare MITPF revenue against listed peers. Click any row to open that company's revenue tab.
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Mithra Pharmaceuticals S.A. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Mithra Pharmaceuticals S.A. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in EUR.
Data sourced from Mithra Pharmaceuticals S.A.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
MITPF revenue · 4 questionsMITPF's trailing twelve-month (TTM) revenue is $0.11B. That is a decrease of 40.06% year-over-year from $0.04B in FY2023.
▸ Source: FMP · Mithra Pharmaceuticals S.A. SEC filings · GAAP · Mithra Pharmaceuticals S.A. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026